# | Title | Journal | Year | Citations |
---|
1 | Automated analysis of free speech predicts psychosis onset in high-risk youths | NPJ Schizophrenia | 2015 | 453 |
2 | The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research | NPJ Schizophrenia | 2020 | 193 |
3 | Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder—a systematic review of the magnetic resonance neuroimaging literature | NPJ Schizophrenia | 2017 | 164 |
4 | Predictors of outcome in early-onset psychosis: a systematic review | NPJ Schizophrenia | 2015 | 161 |
5 | Voxel-based, brain-wide association study of aberrant functional connectivity in schizophrenia implicates thalamocortical circuitry | NPJ Schizophrenia | 2015 | 137 |
6 | The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders | NPJ Schizophrenia | 2017 | 121 |
7 | A machine learning approach to predicting psychosis using semantic density and latent content analysis | NPJ Schizophrenia | 2019 | 121 |
8 | Early interventions in risk groups for schizophrenia: what are we waiting for? | NPJ Schizophrenia | 2016 | 111 |
9 | Thought disorder measured as random speech structure classifies negative symptoms and schizophrenia diagnosis 6 months in advance | NPJ Schizophrenia | 2017 | 107 |
10 | Change in brain network topology as a function of treatment response in schizophrenia: a longitudinal resting-state fMRI study using graph theory | NPJ Schizophrenia | 2016 | 100 |
11 | The proteome of schizophrenia | NPJ Schizophrenia | 2015 | 96 |
12 | Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder | NPJ Schizophrenia | 2016 | 95 |
13 | The clinical course of schizophrenia in women and men—a nation-wide cohort study | NPJ Schizophrenia | 2020 | 93 |
14 | Aerobic exercise and yoga improve neurocognitive function in women with early psychosis | NPJ Schizophrenia | 2015 | 84 |
15 | Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia | NPJ Schizophrenia | 2017 | 84 |
16 | Towards artificial intelligence in mental health by improving schizophrenia prediction with multiple brain parcellation ensemble-learning | NPJ Schizophrenia | 2019 | 71 |
17 | Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task | NPJ Schizophrenia | 2015 | 66 |
18 | Detecting relapse in youth with psychotic disorders utilizing patient-generated and patient-contributed digital data from Facebook | NPJ Schizophrenia | 2019 | 65 |
19 | Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules | NPJ Schizophrenia | 2015 | 64 |
20 | The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis | NPJ Schizophrenia | 2018 | 64 |
21 | In vivo (R)-[11C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis | NPJ Schizophrenia | 2016 | 63 |
22 | Molecular evidence of synaptic pathology in the CA1 region in schizophrenia | NPJ Schizophrenia | 2016 | 62 |
23 | The effect of cognitive remediation in individuals at ultra-high risk for psychosis: a systematic review | NPJ Schizophrenia | 2017 | 62 |
24 | Abnormalities of signal transduction networks in chronic schizophrenia | NPJ Schizophrenia | 2017 | 62 |
25 | The effect of duration of untreated psychosis and treatment delay on the outcomes of prolonged early intervention in psychotic disorders | NPJ Schizophrenia | 2017 | 61 |
26 | The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes | NPJ Schizophrenia | 2015 | 60 |
27 | Risk of weight gain for specific antipsychotic drugs: a meta-analysis | NPJ Schizophrenia | 2018 | 60 |
28 | Language disturbances in schizophrenia: the relation with antipsychotic medication | NPJ Schizophrenia | 2020 | 58 |
29 | Language in schizophrenia: relation with diagnosis, symptomatology and white matter tracts | NPJ Schizophrenia | 2020 | 56 |
30 | A comparison of passive and active estimates of sleep in a cohort with schizophrenia | NPJ Schizophrenia | 2017 | 55 |
31 | Schizophrenia interactome with 504 novel protein–protein interactions | NPJ Schizophrenia | 2016 | 54 |
32 | Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis | NPJ Schizophrenia | 2018 | 53 |
33 | Natural language processing methods are sensitive to sub-clinical linguistic differences in schizophrenia spectrum disorders | NPJ Schizophrenia | 2021 | 53 |
34 | Characterization of molecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patient-derived hiPSC neural cells | NPJ Schizophrenia | 2015 | 52 |
35 | Diverse definitions of the early course of schizophrenia—a targeted literature review | NPJ Schizophrenia | 2018 | 52 |
36 | Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients | NPJ Schizophrenia | 2017 | 51 |
37 | Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics | NPJ Schizophrenia | 2022 | 48 |
38 | Increased cortical expression of the zinc transporter SLC39A12 suggests a breakdown in zinc cellular homeostasis as part of the pathophysiology of schizophrenia | NPJ Schizophrenia | 2016 | 47 |
39 | Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia | NPJ Schizophrenia | 2015 | 46 |
40 | Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction data | NPJ Schizophrenia | 2017 | 45 |
41 | The expression of long noncoding RNA NEAT1 is reduced in schizophrenia and modulates oligodendrocytes transcription | NPJ Schizophrenia | 2019 | 44 |
42 | The language profile of formal thought disorder | NPJ Schizophrenia | 2018 | 43 |
43 | Alterations in the hippocampus and thalamus in individuals at high risk for psychosis | NPJ Schizophrenia | 2016 | 42 |
44 | Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development | NPJ Schizophrenia | 2021 | 42 |
45 | Balanced translocation linked to psychiatric disorder, glutamate, and cortical structure/function | NPJ Schizophrenia | 2016 | 41 |
46 | Sleep endophenotypes of schizophrenia: slow waves and sleep spindles in unaffected first-degree relatives | NPJ Schizophrenia | 2018 | 41 |
47 | NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical course | NPJ Schizophrenia | 2018 | 41 |
48 | Ultrastructural pathology of oligodendrocytes adjacent to microglia in prefrontal white matter in schizophrenia | NPJ Schizophrenia | 2018 | 40 |
49 | Early recovery in the first 24 months of treatment in first-episode schizophrenia-spectrum disorders | NPJ Schizophrenia | 2020 | 40 |
50 | Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia | NPJ Schizophrenia | 2021 | 40 |